Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
US8748417B2 · kind B2 · utility
10Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2013 |
| Grant date | Jun 10, 2014 |
| Priority date | — |
| Expiry date | Mar 13, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows:wherein Y, Z, and R1, and R2 are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.